Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects

NCT06624137 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06624137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06624137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects
Lead sponsor
Yale University
Phase
Observational
Overall status
Terminated
Start date
December 12, 2024
Completion date
June 14, 2026
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, alcohol use disorder (aud), healthy volunteer, major depressive disorder (mdd), migraine, obsessive compulsive disorder (ocd), ocd, opioid use disorder, ptsd, ptsd - post traumatic stress disorder, tobacco use disorder